Eosinophilic Asthma Resource Centre

Welcome, this website is intended for all international healthcare professionals. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

A guide to selecting targeted therapy


In this infographic, we review the definition of severe uncontrolled asthma, discuss the steps toward accurately assessing and diagnosing patients with eosinophilic asthma, and introduce a selection of interleukin 5 (IL-5) biologicals for the targeting of airway inflammation.

Following the infographic, participants should be able to:

  • Recognize the importance of early management and the need for a personalized approach when treating patients with eosinophilic asthma
  • Define severe uncontrolled asthma
  • Discuss clinical criteria used to accurately assess and diagnose eosinophilic status
  • List the different emerging therapies targeting the IL-5 pathway in eosinophilic asthma